Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Elderly psoriatic arthritis patients on TNF-α blockers: results of an Italian multicenter study on minimal disease activity and drug discontinuation rate.

Costa L, Lubrano E, Ramonda R, Chimenti MS, Vezzù M, Perrotta FM, Del Puente A, Peluso R, Bottiglieri P, Lorenzin M, Sunzini F, Darda MA, Fiocco U, Perricone R, Punzi L, Scarpa R, Caso F.

Clin Rheumatol. 2017 Aug;36(8):1797-1802. doi: 10.1007/s10067-017-3697-3. Epub 2017 Jun 7.

PMID:
28589323
2.

Quantitative imaging by pixel-based contrast-enhanced ultrasound reveals a linear relationship between synovial vascular perfusion and the recruitment of pathogenic IL-17A-F+IL-23+ CD161+ CD4+ T helper cells in psoriatic arthritis joints.

Fiocco U, Stramare R, Martini V, Coran A, Caso F, Costa L, Felicetti M, Rizzo G, Tonietto M, Scanu A, Oliviero F, Raffeiner B, Vezzù M, Lunardi F, Scarpa R, Sacerdoti D, Rubaltelli L, Punzi L, Doria A, Grisan E.

Clin Rheumatol. 2017 Feb;36(2):391-399. doi: 10.1007/s10067-016-3500-x. Epub 2016 Dec 20.

PMID:
27995384
3.

Bayesian Quantification of Contrast-Enhanced Ultrasound Images With Adaptive Inclusion of an Irreversible Component.

Rizzo G, Tonietto M, Castellaro M, Raffeiner B, Coran A, Fiocco U, Stramare R, Grisan E.

IEEE Trans Med Imaging. 2017 Apr;36(4):1027-1036. doi: 10.1109/TMI.2016.2637698. Epub 2016 Dec 8.

PMID:
27959806
4.

Pixel-based approach to assess contrast-enhanced ultrasound kinetics parameters for differential diagnosis of rheumatoid arthritis.

Rizzo G, Raffeiner B, Coran A, Ciprian L, Fiocco U, Botsios C, Stramare R, Grisan E.

J Med Imaging (Bellingham). 2015 Jul;2(3):034503. doi: 10.1117/1.JMI.2.3.034503. Epub 2015 Sep 11.

5.

Influenza vaccine with adjuvant on disease activity in psoriatic arthritis patients under anti-TNF-α therapy.

Caso F, Ramonda R, Del Puente A, Darda MA, Cantarini L, Peluso R, Esposito C, Ortolan A, Fiocco U, Punzi L, Scarpa R, Costa L.

Clin Exp Rheumatol. 2016 May-Jun;34(3):507-12. Epub 2016 Mar 11.

PMID:
26967009
6.

How the Mediterranean diet and some of its components modulate inflammatory pathways in arthritis.

Oliviero F, Spinella P, Fiocco U, Ramonda R, Sfriso P, Punzi L.

Swiss Med Wkly. 2015 Nov 2;145:w14190. doi: 10.4414/smw.2015.14190. eCollection 2015. Review.

7.

Ex Vivo Signaling Protein Mapping in T Lymphocytes in the Psoriatic Arthritis Joints.

Fiocco U, Martini V, Accordi B, Caso F, Costa L, Oliviero F, Scanu A, Felicetti M, Frallonardo P, Facco M, Boso D, Molena B, Zambello R, Ramonda R, Cozzi F, Scarpa R, Basso G, Semenzato G, Dayer JM, Doria A, Punzi L.

J Rheumatol Suppl. 2015 Nov;93:48-52. doi: 10.3899/jrheum.150636.

PMID:
26523057
8.

Transcriptional network profile on synovial fluid T cells in psoriatic arthritis.

Fiocco U, Martini V, Accordi B, Caso F, Costa L, Oliviero F, Scanu A, Facco M, Boso D, Gatto M, Felicetti M, Frallonardo P, Ramonda R, Piva L, Zambello R, Agostini C, Scarpa R, Basso G, Semenzato G, Dayer JM, Punzi L, Doria A.

Clin Rheumatol. 2015 Sep;34(9):1571-80. doi: 10.1007/s10067-015-3002-2. Epub 2015 Jul 9.

PMID:
26152611
9.

Vascular perfusion kinetics by contrast-enhanced ultrasound are related to synovial microvascularity in the joints of psoriatic arthritis.

Fiocco U, Stramare R, Coran A, Grisan E, Scagliori E, Caso F, Costa L, Lunardi F, Oliviero F, Bianchi FC, Scanu A, Martini V, Boso D, Beltrame V, Vezzù M, Cozzi L, Scarpa R, Sacerdoti D, Punzi L, Doria A, Calabrese F, Rubaltelli L.

Clin Rheumatol. 2015 Nov;34(11):1903-12. doi: 10.1007/s10067-015-2894-1. Epub 2015 Feb 14.

PMID:
25681071
10.

Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection.

Caso F, Cantarini L, Morisco F, Del Puente A, Ramonda R, Fiocco U, Lubrano E, Peluso R, Caso P, Galeazzi M, Punzi L, Scarpa R, Costa L.

Expert Opin Biol Ther. 2015 May;15(5):641-50. doi: 10.1517/14712598.2015.1011616. Epub 2015 Feb 4. Review.

PMID:
25652590
11.

Metabolic syndrome and its relationship with the achievement of minimal disease activity state in psoriatic arthritis patients: an observational study.

Costa L, Caso F, Ramonda R, Del Puente A, Cantarini L, Darda MA, Caso P, Lorenzin M, Fiocco U, Punzi L, Scarpa R.

Immunol Res. 2015 Feb;61(1-2):147-53. doi: 10.1007/s12026-014-8595-z.

PMID:
25395342
12.

JAK/STAT/PKCδ molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis.

Fiocco U, Accordi B, Martini V, Oliviero F, Facco M, Cabrelle A, Piva L, Molena B, Caso F, Costa L, Scanu A, Pagnin E, Atteno M, Scarpa R, Basso G, Semenzato G, Punzi L, Doria A, Dayer JM.

Immunol Res. 2014 Jan;58(1):61-9. doi: 10.1007/s12026-013-8481-0.

PMID:
24385089
13.

Long-term safety of anti-TNF-α in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients.

Costa L, Caso F, Atteno M, Giannitti C, Spadaro A, Ramonda R, Vezzù M, Del Puente A, Morisco F, Fiocco U, Galeazzi M, Punzi L, Scarpa R.

Clin Rheumatol. 2014 Feb;33(2):273-6. doi: 10.1007/s10067-013-2378-0. Epub 2013 Aug 24.

PMID:
23975363
14.

Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients.

Costa L, Caso F, Atteno M, Del Puente A, Darda MA, Caso P, Ortolan A, Fiocco U, Ramonda R, Punzi L, Scarpa R.

Clin Rheumatol. 2014 Jun;33(6):833-9.

PMID:
23959447
15.

Successful use of rituximab in a young patient with immunoglobulin G4-related disease and refractory scleritis.

Caso F, Fiocco U, Costa L, Sfriso P, Punzi L, Doria A.

Joint Bone Spine. 2014 Mar;81(2):190-2. doi: 10.1016/j.jbspin.2013.07.011. Epub 2013 Aug 9. No abstract available.

PMID:
23932926
16.

Epigallocatechin-3-gallate reduces inflammation induced by calcium pyrophosphate crystals in vitro.

Oliviero F, Sfriso P, Scanu A, Fiocco U, Spinella P, Punzi L.

Front Pharmacol. 2013 Apr 17;4:51. doi: 10.3389/fphar.2013.00051. eCollection 2013.

17.

Remission in early, aggressive rheumatoid arthritis: a multicentre prospective observational Italian study ARPA (Artrite Reumatoide Precoce Aggressiva).

Ceccarelli F, Perricone C, Trotta F, Cuomo G, Pellerito R, Bagnato G, Salaffi F, Caporali R, Cutolo M, Galeazzi M, Fiocco U, Lapadula G, Bombardieri S, Bianchi G, Gorla R, Giardina AR, Gallo G, Giardino AM, Valesini G; Arpa Study Group.

Clin Exp Rheumatol. 2013 May-Jun;31(3):341-9. Epub 2013 Feb 1.

PMID:
23380023
18.

The role of eight polymorphisms in three candidate genes in determining the susceptibility, phenotype, and response to anti-TNF therapy in patients with rheumatoid arthritis.

Ceccarelli F, D'Alfonso S, Perricone C, Carlomagno Y, Alessandri C, Croia C, Barizzone N, Montecucco C, Galeazzi M, Sebastiani GD, Minisola G, Fiocco U, Valesini G.

Clin Exp Rheumatol. 2012 Nov-Dec;30(6):939-42. Epub 2012 Dec 17.

PMID:
22992305
19.

Response to 'Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4'.

Oliviero F, Scanu A, Dayer JM, Fiocco U, Sfriso P, Punzi L.

Arthritis Res Ther. 2012 Sep 12;14(5):405; author reply 406. doi: 10.1186/ar3863. No abstract available.

20.

Blockade of intra-articular TNF in peripheral spondyloarthritis: its relevance to clinical scores, quantitative imaging and synovial fluid and synovial tissue biomarkers.

Fiocco U, Sfriso P, Oliviero F, Lunardi F, Calabrese F, Scagliori E, Cozzi L, Di Maggio A, Nardacchione R, Molena B, Felicetti M, Gazzola K, Stramare R, Rubaltelli L, Accordi B, Costa L, Roux-Lombard P, Punzi L, Dayer JM.

Joint Bone Spine. 2013 Mar;80(2):165-70. doi: 10.1016/j.jbspin.2012.06.016. Epub 2012 Aug 3.

PMID:
22867975
21.

Synovial biomarkers in psoriatic arthritis.

Fiocco U, Oliviero F, Sfriso P, Calabrese F, Lunardi F, Scagliori E, Rubaltelli L, Stramare R, Di Maggio A, Nardacchione R, Cozzi L, Molena B, Felicetti M, Gazzola K, Lo Nigro A, Accordi B, Roux-Lombard P, Dayer JM, Punzi L.

J Rheumatol Suppl. 2012 Jul;89:61-4. doi: 10.3899/jrheum.120246.

PMID:
22751595
22.

Improved detection of synovial boundaries in ultrasound examination by using a cascade of active-contours.

Veronese E, Stramare R, Campion A, Raffeiner B, Beltrame V, Scagliori E, Coran A, Ciprian L, Fiocco U, Grisan E.

Med Eng Phys. 2013 Feb;35(2):188-94. doi: 10.1016/j.medengphy.2012.04.014. Epub 2012 May 22.

PMID:
22626639
23.

Evaluation of finger joint synovial vascularity in patients with rheumatoid arthritis using contrast-enhanced ultrasound with water immersion and a stabilized probe.

Stramare R, Raffeiner B, Ciprian L, Scagliori E, Coran A, Perissinotto E, Fiocco U, Beltrame V, Rubaltelli L.

J Clin Ultrasound. 2012 Mar-Apr;40(3):147-54. doi: 10.1002/jcu.21887. Epub 2012 Jan 30.

PMID:
22287501
24.

Synovial colony-stimulating factor-1 mRNA expression in diffuse pigmented villonodular synovitis.

Molena B, Sfriso P, Oliviero F, Pagnin E, Teramo A, Lunardi F, Stramare R, Scanu A, Nardacchione R, Rubaltelli L, Calabrese F, Punzi L, Fiocco U.

Clin Exp Rheumatol. 2011 May-Jun;29(3):547-50. Epub 2011 Jun 30.

PMID:
21640049
25.

Treatment patterns of anti-TNF agents in Italy: an observational study.

Punzi L, Matucci Cerinic M, Cantini F, Bagnato G, Fiocco U, Ferri C, Bombardieri S.

Reumatismo. 2011 Mar;63(1):18-28.

26.

"Are there any evidences for using the intra-articular TNF-α blockade in resistant arthritis?".

Fiocco U, Punzi L.

Joint Bone Spine. 2011 Jul;78(4):331-4. doi: 10.1016/j.jbspin.2011.01.005. Epub 2011 Feb 25. No abstract available.

PMID:
21353617
27.

Synovial effusion and synovial fluid biomarkers in psoriatic arthritis to assess intraarticular tumor necrosis factor-α blockade in the knee joint.

Fiocco U, Sfriso P, Oliviero F, Roux-Lombard P, Scagliori E, Cozzi L, Lunardi F, Calabrese F, Vezzù M, Dainese S, Molena B, Scanu A, Nardacchione R, Rubaltelli L, Dayer JM, Punzi L.

Arthritis Res Ther. 2010;12(4):R148. doi: 10.1186/ar3090. Epub 2010 Jul 19.

28.

Molecular pathways involved in synovial cell inflammation and tumoral proliferation in diffuse pigmented villonodular synovitis.

Fiocco U, Sfriso P, Lunardi F, Pagnin E, Oliviero F, Scagliori E, Cozzi L, Vezzù M, Molena B, Scanu A, Panziera C, Nardacchione R, Rubaltelli L, Dayer JM, Calabrese F, Punzi L.

Autoimmun Rev. 2010 Sep;9(11):780-4. doi: 10.1016/j.autrev.2010.07.001. Epub 2010 Jul 8. Review.

PMID:
20620241
29.

Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study.

Combe B, Codreanu C, Fiocco U, Gaubitz M, Geusens PP, Kvien TK, Pavelka K, Sambrook PN, Smolen JS, Khandker R, Singh A, Wajdula J, Fatenejad S; Etanercept European Investigators Network.

Ann Rheum Dis. 2009 Jul;68(7):1146-52. doi: 10.1136/ard.2007.087106. Epub 2008 Sep 15.

30.

Co-stimulatory modulation in rheumatoid arthritis: the role of (CTLA4-Ig) abatacept.

Fiocco U, Sfriso P, Oliviero F, Pagnin E, Scagliori E, Campana C, Dainese S, Cozzi L, Punzi L.

Autoimmun Rev. 2008 Oct;8(1):76-82. doi: 10.1016/j.autrev.2008.07.035. Epub 2008 Aug 15. Review.

PMID:
18718877
31.

Pathogenetic and clinical rationale for TNF-blocking therapy in psoriatic arthritis.

Punzi L, Podswiadek M, Sfriso P, Oliviero F, Fiocco U, Todesco S.

Autoimmun Rev. 2007 Sep;6(8):524-8. Epub 2007 Jan 8. Review.

PMID:
17854743
32.

[Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis].

Botsios C, Sfriso P, Furlan A, Ostuni P, Biscaro M, Fiocco U, Todesco S, Punzi L.

Reumatismo. 2007 Jan-Mar;59(1):32-7. Italian.

33.

[Intra-articular treatment with the TNF-alpha antagonist, etanercept, in severe diffuse pigmented villonodular synovitis of the knee].

Fiocco U, Sfriso P, Oliviero F, Sovran F, Scagliori E, Pagnin E, Vezzu M, Cozzi L, Botsios C, Nardacchione R, Di Maggio A, Rubaltelli L, Giacometti C, Calabrese F, Todesco S.

Reumatismo. 2006 Oct-Dec;58(4):268-74. Italian.

34.

[Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatment with infliximab].

Hoxha A, Ruffatti A, Grypiotis P, Podswiadek M, Botsios C, Fiocco U, Punzi L, Todesco S.

Reumatismo. 2006 Apr-Jun;58(2):121-6. Italian.

35.

Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison.

Combe B, Codreanu C, Fiocco U, Gaubitz M, Geusens PP, Kvien TK, Pavelka K, Sambrook PN, Smolen JS, Wajdula J, Fatenejad S; Etanercept European Investigators Network (Etanercept Study 309 Investigators).

Ann Rheum Dis. 2006 Oct;65(10):1357-62. Epub 2006 Apr 10.

36.

Epithelial CXCR3-B regulates chemokines bioavailability in normal, but not in Sjogren's syndrome, salivary glands.

Sfriso P, Oliviero F, Calabrese F, Miorin M, Facco M, Contri A, Cabrelle A, Baesso I, Cozzi F, Andretta M, Cassatella MA, Fiocco U, Todesco S, Konttinen YT, Punzi L, Agostini C.

J Immunol. 2006 Feb 15;176(4):2581-9.

37.

[Differences in pharmacology of tumor necrosis factor (TNF) antagonists].

Fiocco U, Bombardieri S.

Reumatismo. 2005;57(4 Suppl):8-16. Review. Italian.

PMID:
16385350
38.

Rheumatoid and psoriatic knee synovitis: clinical, grey scale, and power Doppler ultrasound assessment of the response to etanercept.

Fiocco U, Ferro F, Vezzù M, Cozzi L, Checchetto C, Sfriso P, Botsios C, Ciprian L, Armellin G, Nardacchione R, Piccoli A, Todesco S, Rubaltelli L.

Ann Rheum Dis. 2005 Jun;64(6):899-905. Epub 2004 Nov 26.

39.

Evaluation of lymph node perfusion using continuous mode harmonic ultrasonography with a second-generation contrast agent.

Rubaltelli L, Khadivi Y, Tregnaghi A, Stramare R, Ferro F, Borsato S, Fiocco U, Adami F, Rossi CR.

J Ultrasound Med. 2004 Jun;23(6):829-36.

PMID:
15244307
40.

[IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy].

Fiocco U, Vezzù M, Cozzi L, Todesco S.

Reumatismo. 2004 Jan-Mar;56(1 Suppl 1):62-73. Review. Italian.

PMID:
15201942
41.

[Infections in patients with rheumatoid arthritis receiving anti-cytokine therapy: biological mechanisms and clinical aspects].

Botsios C, Ostuni P, Sfriso P, Furlan A, Fiocco U, Sgarabotto D, Todesco S.

Reumatismo. 2003 Oct-Dec;55(4):224-35. Review. Italian.

42.

Contrast medium in power Doppler ultrasound for assessment of synovial vascularity: comparison with arthroscopy.

Fiocco U, Ferro F, Cozzi L, Vezzù M, Sfriso P, Checchetto C, Bianchi FC, Nardacchione R, Piccoli A, Todesco S, Rubaltelli L.

J Rheumatol. 2003 Oct;30(10):2170-6.

PMID:
14528513
43.

Vascular changes in psoriatic knee joint synovitis.

Fiocco U, Cozzi L, Chieco-Bianchi F, Rigon C, Vezzù M, Favero E, Ferro F, Sfriso P, Rubaltelli L, Nardacchione R, Todesco S.

J Rheumatol. 2001 Nov;28(11):2480-6.

PMID:
11708422
44.

The thrombin-antithrombin complex in rheumatoid arthritis.

Cella G, Fiocco U, Palla A.

J Rheumatol. 1997 Feb;24(2):410. No abstract available.

PMID:
9035011
45.

Arthroscopic synovectomy in rheumatoid and psoriatic knee joint synovitis: long-term outcome.

Fiocco U, Cozzi L, Rigon C, Chieco-Bianchi F, Baldovin M, Cassisi GA, Gallo C, Doria A, Favaro MA, Piccoli A, de Candia A, Rubaltelli L, Todesco S.

Br J Rheumatol. 1996 May;35(5):463-70.

PMID:
8646438
46.

Long-term sonographic follow-up of rheumatoid and psoriatic proliferative knee joint synovitis.

Fiocco U, Cozzi L, Rubaltelli L, Rigon C, De Candia A, Tregnaghi A, Gallo C, Favaro MA, Chieco-Bianchi F, Baldovin M, Todesco S.

Br J Rheumatol. 1996 Feb;35(2):155-63.

PMID:
8612029
47.

Prospective sonographic and arthroscopic evaluation of proliferative knee joint synovitis.

Rubaltelli L, Fiocco U, Cozzi L, Baldovin M, Rigon C, Bortoletto P, Tregnaghi A, Melanotte PL, di Maggio C, Todesco S.

J Ultrasound Med. 1994 Nov;13(11):855-62.

PMID:
7837332
48.

Early phenotypic activation of circulating helper memory T cells in scleroderma: correlation with disease activity.

Fiocco U, Rosada M, Cozzi L, Ortolani C, De Silvestro G, Ruffatti A, Cozzi E, Gallo C, Todesco S.

Ann Rheum Dis. 1993 Apr;52(4):272-7.

49.

Effect of D-penicillamine on the T cell phenotype in scleroderma. Comparison between treated and untreated patients.

Rosada M, Fiocco U, De Silvestro G, Doria A, Cozzi L, Favaretto M, Todesco S.

Clin Exp Rheumatol. 1993 Mar-Apr;11(2):143-8.

PMID:
7685256
50.

[New trends in immunotherapy of rheumatoid arthritis].

Todesco S, Fiocco U, Cozzi L.

Clin Ter. 1991 Dec 15-31;139(5-6):257-63. Review. Italian. No abstract available.

PMID:
1802515

Supplemental Content

Loading ...
Support Center